| RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN (NCT01009346) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-10-01 |
| Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy Individuals (NCT01201577) | University of Nottingham | 2009-10-01 |
| Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition (NCT01627847) | Dr. Reddy's Laboratories Limited | 2009-10-01 |
| Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function (NCT01028768) | Nycomed | 2009-10-01 |
| Mindfulness Based Relapse Prevention: Efficacy and Mechanisms (NCT01159535) | University of Washington | 2009-10-01 |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer (NCT00970580) | Biogen | 2009-10-01 |
| Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen (NCT00972127) | Merz Pharmaceuticals GmbH | 2009-10-01 |
| Safety and Tolerability of Trospium Chloride and Metformin Hydrochloride in Healthy Subjects (NCT00986401) | Allergan | 2009-10-01 |
| Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib (NCT00993499) | Boehringer Ingelheim | 2009-10-01 |
| Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects (NCT00995085) | Alcobra Ltd. | 2009-10-01 |
| A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm (NCT00964730) | Teva Branded Pharmaceutical Products R&D, Inc. | 2009-10-01 |
| Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy (NCT00992290) | Virginia Commonwealth University | 2009-10-01 |
| Implant System for Fixation of Cranial Bone Flaps After Craniotomy for Brain Surgery (NCT00797979) | Assistance Publique - Hôpitaux de Paris | 2009-10-01 |
| Cross-Over Broccoli Sprouts Trial (NCT01008826) | Johns Hopkins Bloomberg School of Public Health | 2009-10-01 |
| Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer (NCT00999843) | Fudan University | 2009-10-01 |
| Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction (NCT00972569) | Mayo Clinic | 2009-10-01 |
| Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 (NCT01006798) | Emergent BioSolutions | 2009-10-01 |
| Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects (NCT02171572) | Boehringer Ingelheim | 2009-10-01 |
| Safety Assessment of Atomoxetine With MA IV Administration (NCT01019707) | University of California, Los Angeles | 2009-10-01 |
| Drug Interaction Between CKD-501 and Metformin (NCT01005160) | Chong Kun Dang Pharmaceutical | 2009-10-01 |
| Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function (NCT00949663) | Washington University School of Medicine | 2009-10-01 |
| A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects (NCT01030315) | Hanmi Pharmaceutical Company Limited | 2009-10-01 |
| AZD8683 Single Ascending Dose Study (NCT00979849) | AstraZeneca | 2009-10-01 |
| Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation (NCT00996359) | University of Medicine and Dentistry of New Jersey | 2009-10-01 |
| Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma (NCT00976183) | Gynecologic Oncology Associates | 2009-10-01 |
| The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery (NCT00997217) | Seoul National University Hospital | 2009-10-01 |
| A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies (NCT01013818) | Human Genome Sciences Inc. | 2009-10-01 |
| Estrogen Receptor Beta Agonists (Eviendep) and Polyp Recurrence (NCT01402648) | CM&D Pharma Limited | 2009-10-01 |
| Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects (NCT01053520) | Abbott | 2009-10-01 |
| Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition (NCT01504516) | Dr. Reddy's Laboratories Limited | 2009-10-01 |
| Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient (NCT01069913) | Biogen | 2009-10-01 |
| A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer (NCT00974584) | Genentech, Inc. | 2009-10-01 |
| Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation (NCT00956020) | The New York Eye & Ear Infirmary | 2009-10-01 |
| Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients (NCT01003678) | Roswell Park Cancer Institute | 2009-10-01 |
| Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma (NCT00996957) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2009-10-01 |
| Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases (NCT01003912) | Joanne Kurtzberg, MD | 2009-10-01 |
| Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer (NCT01126450) | Case Comprehensive Cancer Center | 2009-10-01 |
| Shoulder Muscle Massage Shoulder Stiffness (NCT01022827) | National Taiwan University Hospital | 2009-10-01 |
| Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT) (NCT01004770) | GE Healthcare | 2009-10-01 |
| Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer (NCT01031446) | Vanderbilt-Ingram Cancer Center | 2009-10-01 |
| Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma (NCT00986037) | AbbVie | 2009-10-01 |
| A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402 (NCT02375256) | Aeras | 2009-10-01 |
| Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia (NCT00995137) | St. Jude Children's Research Hospital | 2009-10-01 |
| A Pharmacokinetic Study of CJ30001 and HKB0701/SLM0807 in Healthy Subject (NCT01370681) | HK inno.N Corporation | 2009-10-01 |
| Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer (NCT01458847) | BioCis Pharma Ltd | 2009-10-01 |
| Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy (NCT01046240) | Clinica Universidad de Navarra, Universidad de Navarra | 2009-10-01 |
| Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. (NCT00985543) | Kirby Institute | 2009-10-01 |
| Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas (NCT00939991) | Katy Peters | 2009-10-01 |
| A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (NCT01009424) | Hoffmann-La Roche | 2009-10-01 |
| Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) (NCT00996723) | St. Jude Children's Research Hospital | 2009-10-01 |
| A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers (NCT01007409) | Boryung Pharmaceutical Co., Ltd | 2009-10-01 |
| Diaphragm Activity During Incentive Spirometry and Diaphragmatic Breathing (NCT00997737) | Hospital Sirio-Libanes | 2009-10-01 |
| Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy (NCT00957918) | Neuraltus Pharmaceuticals, Inc. | 2009-10-01 |
| Kinetic Method to Detect Dehydration (NCT01062776) | Sodertalje Hospital | 2009-10-01 |
| Mesenchymal Stem Cells and Myocardial Ischemia (NCT01076920) | University Hospital, Toulouse | 2009-10-01 |
| A Study of E7050 Administered Orally to Patients With Advanced Solid Tumors (NCT00921869) | Eisai Co., Ltd. | 2009-10-01 |
| Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules (NCT01073553) | Bayer | 2009-10-01 |
| VX-950-TiDP24-C136 - A Trial to Evaluate the Effect of Telaprevir (TVR) on the Results of Electrocardiograms (Electric Recording of the Heart) in Healthy Volunteers (NCT00973388) | Tibotec BVBA | 2009-10-01 |
| Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea (NCT00995787) | AstraZeneca | 2009-10-01 |
| Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity (NCT00990223) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-10-01 |
| To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate (NCT01009242) | UCB Pharma | 2009-10-01 |
| Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer (NCT00807781) | Washington University School of Medicine | 2009-10-01 |
| Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne (NCT01682200) | Medivet Pty Ltd | 2009-10-01 |
| Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation (NCT01207193) | Royan Institute | 2009-10-01 |
| Evaluation of Food Effect on Pharmacokinetics of Vismodegib (NCT01174264) | National Cancer Institute (NCI) | 2009-10-01 |
| Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response (NCT01128803) | Nantes University Hospital | 2009-10-01 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer (NCT01020305) | Sandy Srinivas | 2009-10-01 |
| A Study of Doripenem in Infants Less Than 12 Weeks of Age (NCT01381848) | Janssen Research & Development, LLC | 2009-10-01 |
| A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects (NCT01081704) | Centocor, Inc. | 2009-10-01 |
| A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions. (NCT01499758) | Ranbaxy Laboratories Limited | 2009-10-01 |
| A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth (NCT00989391) | Pfizer | 2009-10-01 |
| Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects (NCT01007929) | AstraZeneca | 2009-10-01 |
| Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM) (NCT00948389) | Bristol-Myers Squibb | 2009-10-01 |
| Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients (NCT00999882) | AstraZeneca | 2009-10-01 |
| A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer (NCT00992745) | Molecular Insight Pharmaceuticals, Inc. | 2009-10-01 |
| A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users (NCT00975481) | Pfizer | 2009-10-01 |
| A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients (NCT01561833) | Yale University | 2009-10-01 |
| A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days (NCT00964340) | GlaxoSmithKline | 2009-10-01 |
| Efficacy of a Prebiotic Galactooligosaccharide to Reduce Metabolic Syndrome Risk Factors in Overweight Adults (NCT01004120) | Clasado | 2009-10-01 |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer (NCT00953576) | Dana-Farber Cancer Institute | 2009-09-29 |
| GSK618334 Repeat Dose Study (NCT01036061) | GlaxoSmithKline | 2009-09-28 |
| Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) (NCT00954512) | Merck Sharp & Dohme LLC | 2009-09-25 |
| Study of MLN8237 in Participants With Advanced Solid Tumors (NCT00962091) | Millennium Pharmaceuticals, Inc. | 2009-09-25 |
| Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001) (NCT01215175) | Merck Sharp & Dohme LLC | 2009-09-25 |
| A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors (NCT00994071) | National Cancer Institute (NCI) | 2009-09-22 |
| Effects of Repeat Dosing of GSK1521498 (NCT00976105) | GlaxoSmithKline | 2009-09-22 |
| Phase 0 Microdose Study (NCT00975936) | GlaxoSmithKline | 2009-09-21 |
| Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma (NCT00939770) | Children's Oncology Group | 2009-09-21 |
| A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male Subjects (NCT05918627) | Kadmon, a Sanofi Company | 2009-09-21 |
| GSK962040 Drug-drug Interaction Study With Ketoconazole (NCT01039974) | GlaxoSmithKline | 2009-09-18 |
| A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda (NCT01371682) | GlaxoSmithKline | 2009-09-18 |
| Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform (NCT00977431) | Boehringer Ingelheim | 2009-09-17 |
| Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects (NCT01000597) | GlaxoSmithKline | 2009-09-17 |
| A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers (NCT00978393) | Novo Nordisk A/S | 2009-09-16 |
| Safety Study of Tezepelumab (AMG 157) in Healthy Adults (NCT00972179) | Amgen | 2009-09-15 |
| A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015) (NCT00963547) | Merck Sharp & Dohme LLC | 2009-09-15 |
| Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors (NCT00878904) | University of California, San Francisco | 2009-09-13 |
| Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies (NCT00921739) | Duke University | 2009-09-11 |
| A Study of LY2801653 in Advanced Cancer (NCT01285037) | Eli Lilly and Company | 2009-09-09 |
| Paxil CR Bioequivalence Study Brazil (NCT01316926) | GlaxoSmithKline | 2009-09-09 |